In the latest trading session, 2.73 million Teladoc Health Inc (NYSE:TDOC) shares changed hands as the company’s beta touched 1.25. With the company’s most recent per share price at $11.44 changed hands at -$0.07 or -0.65% at last look, the market valuation stands at $1.97B. TDOC’s current price is a discount, trading about -39.42% off its 52-week high of $15.95. The share price had its 52-week low at $6.76, which suggests the last value was 40.91% up since then.
Analysts gave the Teladoc Health Inc (TDOC) stock a consensus recommendation rating of Hold, calculated at a mean rating of 2.57. If we narrow down to specifics, the data shows that 0 out of 19 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 10 recommended TDOC as a Hold, 9 felt it is a Buy and 0 rated the stock as Underweight. Teladoc Health Inc’s EPS for the current quarter is expected to be -0.29.
Teladoc Health Inc (NYSE:TDOC) trade information
Instantly TDOC was in red as seen in intraday trades today. With action -20.20%, the performance over the past five days has been red. The company’s shares are showing year-to-date upside of 25.80%, with the 5-day performance at -20.20% in the red. However, in the 30-day time frame, Teladoc Health Inc (NYSE:TDOC) is 12.77% up.
The consensus price target for the stock as assigned by Wall Street analysts is 11, meaning bulls need a downside of -4.0% from its recent market value. According to analyst projections, TDOC’s forecast low is 9 with 13 as the target high. To hit the forecast high, the stock’s price needs a -13.64% plunge from its current level, while the stock would need to tank 21.33% for it to hit the projected low.
Teladoc Health Inc (TDOC) estimates and forecasts
Year-over-year growth is forecast to reach -1.31% down from the last financial year.
Consensus estimates given by 25 financial analysts project the company’s revenue in the current quarter to hit an average of 639.44M. 19 analysts are of the opinion that Teladoc Health Inc’s revenue for the current quarter will be 633.03M. The company’s revenue for the corresponding quarters a year ago was 660.53M and 646.13M respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at -3.19%. The estimates for the next quarter sales put growth at -2.03%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 1.91%. The 2025 estimates are for Teladoc Health Inc earnings to decrease by -334.11%, but the outlook for the next 5-year period is at 13.78% per year.
Teladoc Health Inc (NYSE:TDOC)’s Major holders
VANGUARD GROUP INC holds the second largest percentage of outstanding shares, with 10.2643% or 17.22 million shares worth $168.38 million as of 2024-06-30.
Among Mutual Funds, the top two as of Sep 30, 2024 were Vanguard Total Stock Market Index Fund and iShares Russell 2000 ETF. With 5.34 shares estimated at $60.92 million under it, the former controlled 3.10% of total outstanding shares. On the other hand, iShares Russell 2000 ETF held about 2.80% of the shares, roughly 4.82 shares worth around $55.03 million.
